Opinion: Fecal transplants are saving lives — but are now at risk

Twenty years ago, a respected colleague asked me to perform a “poop transplant” on a local schoolteacher with multiply recurrent C. difficile infection.  I was incredulous and skeptical, but my colleague (a friend but a forceful one) persisted until I ultimately acquiesced. 

Soon I was in a hazmat suit blenderizing stool and performing my first (subsequently named) fecal microbiota transplant, or FMT. My patient was cured, and I began two decades of care of thousands of patients with refractory C. difficile infection, a therapy that might seem counterintuitive (stool as medicine?) but in fact, is quite biologically rational:  C. difficile thrives in a disturbed, damaged colonic microbiome. The transplant repairs the damage so the bacteria no longer thrive.

Read the rest…

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!